Investor
News & Events
Financial Reports
Stock Information
Corporate Governance
Contacts & Alerts
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 14, 2014- Danaher Corporation announces all-cash tender offer for all publicly held registered shares of Nobel Biocare Holding AG ("Nobel Biocare") at a purchase price of CHF 17.10 per share, representing a total enterprise value of approximately $2.2 billion including debt assumed and net of cash acquired, recommended by Nobel Biocare's Board of Directors.Danaher Corporation (NYSE:DHR) has entered into a definitive transaction agreement with Nobel Biocare Holding AG ("Nobel Biocare") (SIX Swiss Exchange: NOBN) pursuant to which Danaher Corporation...
-
Sep 9, 2014
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will present at the Morgan Stanley...
-
Sep 9, 2014
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on October...
-
Sep 2, 2014
Danaher Corporation (NYSE: DHR) today announced that the Company's Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President...
-
Jul 17, 2014
Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2014. Net earnings for the quarter ended June 27, 2014 were $676.4 million, or $0.95 per share on a diluted basis,...